Search results - 27 results

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.

1, 2022. Inclusion criteria were population-based surveys in men aged 15 years or older or HPV prevalence studies with a sample size of at least 50 men with no HPV-related pathology or known risk ...

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.

detection and separate identification of 14 hrHPV types. Here, we present the clinical validation of the test in SurePath samples in comparison to a clinically validated reference test, the GP5 +/6+Enzyme ...

Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.

a study protocol designed to set up a framework for test validation of SARS-CoV-2 virus assays. Using clinical samples collated from VALCOR, the performance of Aptima SARS-CoV-2 assay was assessed against ...

Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services

underscreened women urine self-sampling vaginal self-sampling Abstract: Self-sampling may improve participation in cervical cancer secondary prevention programs by women who do not respond or respond irregularly ...

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

HPV SCREENING self-sampling self-sampling kits Abstract: BACKGROUND: Human papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among ...

The European response to the WHO call cervical cancer as a public health problem

achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, ...

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

self-sampling urine VALHUDES Abstract: BACKGROUND Interventions to reach women who do not participate regularly in screening may reduce the risk of cervical cancer. Self-collection of a vaginal specimen has been ...

Tackling cervical cancer in Europe amidst the COVID-19 pandemic.

applied on self-collected samples, a strategy that might be used to reach underscreened populations. In May, 2018, the WHO Director General launched a call to eliminate cervical cancer by vaccinating at ...

QR code

QR code for this page URL